GERM vs. CNCR

Last updated Jun 4, 2026

GERM (Amplify Treatments, Testing and Advancements ETF) and CNCR (Loncar Cancer Immunotherapy ETF) are both Health & Biotech Equities funds - GERM tracks the Prime Treatments, Testing and Advancements Index while CNCR tracks the Loncar Cancer Immunotherapy Index. Both are passively managed. GERM charges 0.68%/yr vs 0.79%/yr for CNCR.

Performance

GERM vs. CNCR - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Amplify Treatments, Testing and Advancements ETF (GERM) and Loncar Cancer Immunotherapy ETF (CNCR). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

GERM

• 1D: 0.00%
• 1M: 0.00%
• YTD: 0.00%
• 6M: 0.00%
• 1Y: 0.00%
• 3Y*: —
• 5Y*: —
• 10Y*: —

CNCR

• 1D: 0.00%
• 1M: 0.00%
• YTD: —
• 6M: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

GERM vs. CNCR - Yearly Performance Comparison

	2026 (YTD)
GERM Amplify Treatments, Testing and Advancements ETF	0.00%
CNCR Loncar Cancer Immunotherapy ETF	0.00%

GERM vs. CNCR - Sectors Allocation Comparison

Sectors	GERM	CNCR
Healthcare	99.3%	96.6%
Financial Services	0.4%	3.3%
Basic Materials	-	-
Communication Services	-	-
Consumer Cyclical	-	-
Consumer Defensive	-	-
Energy	-	-
Industrials	-	-
Real Estate	-	-
Technology	-	-
Utilities	-	-

Return for Risk

GERM vs. CNCR - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Amplify Treatments, Testing and Advancements ETF (GERM) and Loncar Cancer Immunotherapy ETF (CNCR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

Drawdowns

GERM vs. CNCR - Drawdown Comparison

The maximum GERM drawdown since its inception was 0.00%, which is greater than CNCR's maximum drawdown of 0.00%. Use the drawdown chart below to compare losses from any high point for GERM and CNCR.

Drawdown Indicators

	GERM	CNCR	Difference
Max Drawdown Largest peak-to-trough decline	0.00%	0.00%	0.00%
Max Drawdown (1Y) Largest decline over 1 year	0.00%	—	—
Current Drawdown Current decline from peak	0.00%	0.00%	0.00%
Average Drawdown Average peak-to-trough decline	0.00%	0.00%	0.00%
Ulcer Index Depth and duration of drawdowns from previous peaks	0.00%	—	—

Volatility

Volatility by Period

	GERM	CNCR	Difference
Volatility (1M) Calculated over the trailing 1-month period	0.00%	—	—
Volatility (6M) Calculated over the trailing 6-month period	0.00%	—	—
Volatility (1Y) Calculated over the trailing 1-year period	0.00%	0.00%	0.00%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	0.00%	0.00%	0.00%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	0.00%	0.00%	0.00%

GERM vs. CNCR - Expense Ratio Comparison

GERM has a 0.68% expense ratio, which is lower than CNCR's 0.79% expense ratio.

Dividends

GERM vs. CNCR - Dividend Comparison

Neither GERM nor CNCR has paid dividends to shareholders.

Tickers have no history of dividend payments

Frequently Asked Questions

Which ETF is better, GERM or CNCR?

On fees, GERM is cheaper at 0.68% per year. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF is cheaper, GERM or CNCR?

GERM is cheaper with a 0.68% expense ratio, compared with 0.79% for CNCR.

Which ETF pays a higher dividend yield, GERM or CNCR?

GERM and CNCR have nearly identical dividend yields, around 0.00%.

What is the main difference between GERM and CNCR?

GERM tracks Prime Treatments, Testing and Advancements Index, while CNCR tracks Loncar Cancer Immunotherapy Index. They also come from different issuers: Amplify and Exchange Traded Concepts. Their fees differ too: 0.68% for GERM and 0.79% for CNCR.